Evaluation of Safety Profiles of Drugs for Blood Cancer Approved in Japan

Time

Mon, Jun 15 9:30AM
M 05

Title

Evaluation of Safety Profiles of Drugs for Blood Cancer Approved in Japan

Abstract Summary

Drugs for blood cancer approved in Japan from 1999 to 2013 were analyzed. NOAEL, maximum approved dose, and exposure level at NOAEL and maximum approved dose were obtained from dossiers available on the PMDA website. Safety indices were calculated as ratios of animal to human parameters.

Poster Presenter

Sachie Kubota
MSc,
Student,
Josai International University
Japan